Taxol-Loaded MSC-Derived Exosomes Provide a Therapeutic Vehicle to Target Metastatic Breast Cancer and Other Carcinoma Cells
MSC-derived exosomes display, among others, an efficient biocompatibility and a reduced intrinsic immunogenicity, representing a valuable vehicle for drug delivery in a tumor-therapeutic approach. Following treatment of several human mesenchymal stroma/stem-like cell (MSC) populations with sub-letha...
Main Authors: | Catharina Melzer, Vanessa Rehn, Yuanyuan Yang, Heike Bähre, Juliane von der Ohe, Ralf Hass |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-06-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/11/6/798 |
Similar Items
-
Anti-Tumor Effects of Exosomes Derived from Drug-Incubated Permanently Growing Human MSC
by: Catharina Melzer, et al.
Published: (2020-10-01) -
Potential Role of MSC/Cancer Cell Fusion and EMT for Breast Cancer Stem Cell Formation
by: Ralf Hass, et al.
Published: (2019-09-01) -
Altered Tumor Plasticity after Different Cancer Cell Fusions with MSC
by: Catharina Melzer, et al.
Published: (2020-11-01) -
Spontaneous Fusion of MSC with Breast Cancer Cells Can Generate Tumor Dormancy
by: Catharina Melzer, et al.
Published: (2021-05-01) -
MSC stimulate ovarian tumor growth during intercellular communication but reduce tumorigenicity after fusion with ovarian cancer cells
by: Catharina Melzer, et al.
Published: (2018-10-01)